Crinetics Pharmaceuticals Inc (CRNX)

Operating Expenses

$157.42M

Quarterly · Period ending: · USD

CRNX logo

CRNX Operating Expenses

Latest reported$157.42M
CRNX Quarterly Operating Expenses ($2.61M → $157.42M)
High-resolution chart · PNG

CRNX operating expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Crinetics Pharmaceuticals Inc Operating Expenses — Quarterly (USD)
Period endingOperating Expenses (USD)
157,423,000
150,912,000
139,827,000
142,729,000
130,143,000
111,766,000
28,179,000
25,892,000
83,182,000
74,169,000
17,078,000
59,323,000
53,983,000
50,657,000
48,265,000
43,912,000
43,484,000
36,958,000
31,966,000
6,227,000
5,602,000
5,334,000
21,791,000
18,451,000
16,929,000
17,782,000
15,214,000
15,229,000
13,345,000
10,044,000
9,431,000
8,070,000
5,683,000
5,526,000
2,501,000
2,374,000
1,643,000
2,609,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.